← Back to Search

P-F texting component for Suicide

N/A
Waitlist Available
Led By Ewa Czyz
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights

Study Summary

This trial is testing whether a text message intervention can help reduce suicide risk in adolescents.

Eligible Conditions
  • Suicide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participating parents' satisfaction with the intervention
Percentage of eligible participants who agree to participate in the study
Percentage of participants who complete follow-up assessments
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: A-F texting plus P-F texting componentExperimental Treatment2 Interventions
A-F texting plus P-F texting component arm includes the A-F component, as above, and P-F component. The P-F component includes an embedded micro-randomized trial (MRT) involving two daily randomizations to P-F message vs. no message conditions for the duration of the 6-week intervention. Participants who are randomized to this arm will be randomized twice each day (morning and evening) to either receive or not receive the P-F message at each randomization.
Group II: A-F texting componentExperimental Treatment1 Intervention
The A-F texting component will include content consistent with best-practice recommendations for parents to buffer youth against suicide risk.
Group III: Control (standard care)Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
A-F texting component
2021
N/A
~240
P-F texting component
2021
N/A
~240

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,676 Total Patients Enrolled
18 Trials studying Suicide
11,405 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,867 Total Patients Enrolled
112 Trials studying Suicide
1,156,579 Patients Enrolled for Suicide
Ewa CzyzPrincipal InvestigatorUniversity of Michigan
2 Previous Clinical Trials
382 Total Patients Enrolled
2 Trials studying Suicide
382 Patients Enrolled for Suicide

Media Library

P-F texting component Clinical Trial Eligibility Overview. Trial Name: NCT05058664 — N/A
Suicide Research Study Groups: Control (standard care), A-F texting component, A-F texting plus P-F texting component
Suicide Clinical Trial 2023: P-F texting component Highlights & Side Effects. Trial Name: NCT05058664 — N/A
P-F texting component 2023 Treatment Timeline for Medical Study. Trial Name: NCT05058664 — N/A
Suicide Patient Testimony for trial: Trial Name: NCT05058664 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment now open for this clinical investigation?

"The clinicaltrial.gov website displays that this particular medical trial is no longer in need of patients, as it was last edited on October 25th 2022. However, there are still 352 other studies actively recruiting volunteers for their research initiatives at the moment."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
What site did they apply to?
The University of Michigan
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Tried meds, therapy ect, tms, spravato, iv ketamine.
PatientReceived 2+ prior treatments
~70 spots leftby Apr 2025